Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics™
Rewinds
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Search
Sunday, October 20, 2019
About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A…
Rivaroxaban potentially inferior to vitamin K antagonists for treatment of thrombotic…
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction…
Development of Anti-Drug Antibodies to Infliximab (Remicade®) and Adalimumab (Humira®) in…
Classics™
Rewinds
2 Minute Medicine Rewind October 14, 2019
2 Minute Medicine Rewind October 7, 2019
2 Minute Medicine Rewind September 30, 2019
2 Minute Medicine Rewind September 23, 2019
2 Minute Medicine Rewind September 16, 2019
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Tag: tyrosine kinase inhibitor
Quick Take: Pexidartinib versus placebo for advanced tenosynovial giant cell tumour...
Donna Leet
-
July 1, 2019
0
2 Minute Medicine Rewind June 24, 2019
Donna Leet
-
June 24, 2019
0
Sorafenib increases progression-free survival in patients with desmoid tumors
Dayton McMillan
-
December 25, 2018
0
All-time hits
The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics...
July 16, 2013
The CLOT trial: Dalteparin versus warfarin [Classics Series]
December 7, 2014
Updated JNC 8 guidelines for antihypertensive drugs released
December 19, 2013
